Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 6

Sponsor Class

OTHER 6NIH 1INDUSTRY 1

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 852Neoplasms 643Prostatic Neoplasms 439Lung Neoplasms 359Colorectal Neoplasms 327Carcinoma, Non-Small-Cell Lung 318Leukemia, Myeloid, Acute 251Pancreatic Neoplasms 218Brain Neoplasms 202Multiple Myeloma 198Neoplasm Metastasis 191Carcinoma, Hepatocellular 178Head and Neck Neoplasms 176Glioblastoma 167Precursor Cell Lymphoblastic Leukemia-Lymphoma 166Melanoma 153Ovarian Neoplasms 149Squamous Cell Carcinoma of Head and Neck 148Rectal Neoplasms 134Recurrence 132Hematologic Neoplasms 125Sarcoma 124Uterine Cervical Neoplasms 117Stomach Neoplasms 116Carcinoma, Renal Cell 115Triple Negative Breast Neoplasms 114Glioma 114Motor Activity 100Myelodysplastic Syndromes 96Esophageal Neoplasms 96

Interventions

maltodextrin 1Contraceptives, Oral 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Metabolic Syndrome × 90 days × Clear all
NCT06852365 2026-06-01

COR-PCOS

University of Pennsylvania

Phase 2 Recruiting
100 enrolled

Polycystic Ovary Syndrome, Metabolic Syndrome

NCT05950282 2026-05-01

DAISY

Lilli Health

Recruiting
150 enrolled
Other

Diabetes Mellitus, Type 2, Hyperinsulinism, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Metabolic Syndrome

NCT06793072 2026-03-18

Adipokines in Polycystic Ovary Syndrome

Jagiellonian University

Recruiting
300 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome

NCT06793085 2026-03-18

Pro- and Anti-inflammatory Cytokines in PCOS

Jagiellonian University

Recruiting
100 enrolled

Insulin Resistance, Menstruation Disturbances, Polycystic Ovary Syndrome, Metabolic Syndrome

NCT06793098 2026-03-18

Functional Proteins in Polycystic Ovary Syndrome

Jagiellonian University

Recruiting
100 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome

NCT06551285 2026-03-17

Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Recruiting
120 enrolled

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡